Investors impatient for Alzheimer’s cure By: MarketWatch July 22, 2015 at 11:40 AM EDT Investors show signs of impatience about drugs that are being tested as a treatment for Alzheimer’s disease. Read More >> Related Stocks: Biogen Idec Eli Lilly